MRI prediction of precapillary pulmonary hypertension according to the sixth world symposium on pulmonary hypertension by Whitfield, A.J. et al.
This is a repository copy of MRI prediction of precapillary pulmonary hypertension 
according to the sixth world symposium on pulmonary hypertension.
White Rose Research Online URL for this paper:
http://eprints.whiterose.ac.uk/155393/
Version: Published Version
Article:
Whitfield, A.J., Solanki, R., Johns, C.S. et al. (3 more authors) (2019) MRI prediction of 
precapillary pulmonary hypertension according to the sixth world symposium on pulmonary
hypertension. Radiology. 192078. ISSN 0033-8419 
https://doi.org/10.1148/radiol.2019192078
© 2019 Radiological Society of North America. Uploaded in accordance with the 
publisher's self-archiving policy. Article available under the terms of the CC-BY-NC-ND 
licence (https://creativecommons.org/licenses/by-nc-nd/4.0/). 
eprints@whiterose.ac.uk
https://eprints.whiterose.ac.uk/
Reuse 
This article is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 
(CC BY-NC-ND) licence. This licence only allows you to download this work and share it with others as long 
as you credit the authors, but you can’t change the article in any way or use it commercially. More 
information and the full terms of the licence here: https://creativecommons.org/licenses/ 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
COMMUNICATIONS • LETTERS TO THE EDITOR
Letters to the Editor
MRI Prediction of Precapillary Pulmonary 
Hypertension according to the Sixth World 
Symposium on Pulmonary Hypertension
From
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Jim Wild, PhD,‡ and Andrew J. Swift, PhD‡
University of Sheield, Beech Hill Rd, Sheield S10 2TN, 
England* 
e-mail: ajwhitield1878@gmail.com
Departments of Infection, Immunity and Cardiovascular 
Disease,† and Department of Academic Radiology,‡ 
University of Sheield, Sheield, England 
Editor:
he Sixth World Symposium on Pulmonary Hyperten-
sion recommends that precapillary pulmonary hyperten-
sion (PH) be deined by a mean pulmonary artery pressure 
(mPAP) of greater than 20 mm Hg as well as a pulmonary 
vascular resistance (PVR) of at least 3 Woods units (WU) 
(1). Herein, we update the results from our article published 
in the January 2019 issue of Radiology (2) to relect this new 
threshold. In our study, we derived two regression models 
based on cardiopulmonary vascular MRI measurements to 
predict mPAP in a population of patients with suspected PH 
from the ASPIRE registry (Assessing the Spectrum of Pul-
monary Hypertension Identiied at a Referral Center). At 
repeat analysis, the speciicity of these models was reduced 
by the inclusion of PVR as a diagnostic indicator of PH. 
herefore, in the same cohort, we now propose a new model 
using binary logistical regression to detect precapillary PH 
by using the new deinition of mPAP greater than 20 mm 
Hg and a PVR of at least 3 WU.
Of the 603 patients in our study, PVR data were not 
available for 52 (9%). In the derivation cohort (n = 270), 
240 patients had precapillary PH. Using the derivation 
cohort, we generated a new cardiac MRI-based model us-
ing binary logistic regression to predict mPAP greater than 
20 mm Hg and PVR of at least 3 WU. he following re-
gression equation was identiied: precapillary PH status 
(arbitrary units) = 27.7 1 5.75log
e
(interventricular septal 
angle [degree of arc]) 1 1.899log
e
(right ventricular mass/
left ventricular mass) 1 0.004 (diastolic pulmonary artery 
area [in square millimeters]). A value of greater than 1 was 
diagnostic of precapillary PH at receiver operating charac-
teristic analysis.
In the validation cohort (n = 281) of 260 patients with 
PH and 21 patients without PH, the model had an area 
under the receiver operating characteristic curve of 0.93 
(95% conidence interval [CI]: 0.89, 0.97). From the 2 3 
2 contingency table analysis, the sensitivity, speciicity, pos-
itive predictive value, and negative predictive value were 
80% (202 of 252 patients; 95% CI: 75%, 95%), 90% (18 
of 20 patients; 95% CI: 67%, 98%), 99% (202 of 204 pa-
tients; 95% CI: 96%, 100%), and 27% (18 of 68 patients; 
95% CI: 17%, 39%), respectively. Further work to validate 
this equation in larger populations in the tertiary referral 
setting and in screening populations with larger numbers 
of patients without PH is now necessary.
In conclusion, for identiication of patients with mPAP 
greater than 20 mm Hg and PVR of at least 3 WU, we 
recommend the use of this new cardiopulmonary vascular 
MRI regression model.
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